Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world prospective cohort of oral isotretinoin dosing patterns in moderate-to-severe acne
ChiCTR2600132615Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of isotretinoin in acne vulgaris, sponsored by West China Hospital of Sichuan University. Primary endpoint: Treatment success rate at Week 24 by Investigator's Global Assessment. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
isotretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on ChiCTR2600132615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600132615.